{"name":"Indigo Therapeutics","slug":"indigo-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxOZ2c5bGExRXZCNnd6OVdIeC05Z1lkYXBTbnIxLWNGaDlXQ0FZeU0zQ3EtVFduTUVDZU9pM1dkb0NxNjBwUTcwY0FMaXg2RDNuYmdicklueU16LV9aNGQ5anU3c2JPd1JsWWFkY1J0cHFTLVhXTUR0QmdjenZpY0lVaWNodTd6aW9xNkZXRFBzaHZ4LXRiTW1zVjFNanBCbFcwc2lRREpkSDNhcTZiS1JqanJmbVV0SFFnZnplUmxJLU41ck1QZDIyN1Z1TWVlak91OHk5YkdkVFBvT05wZjJQMlN0SHRlenNLRW9Tb0xTTFhlQnZrcHc?oc=5","date":"2026-04-08","type":"pipeline","source":"Upstox","summary":"Stocks to watch, April 8: Infosys, L&T, Asian Paints, BPCL, IndiGo, banks, realty, auto, Aurobindo Pharma - Upstox","headline":"Stocks to watch, April 8: Infosys, L&T, Asian Paints, BPCL, IndiGo, banks, realty, auto, Aurobindo Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxPMDlYbXdJVzJ3a2o1M2piYzdBR3E5SzhoOExKZDk0NnN0bjBJM2tEWV90SmNnRkUydkd4cWJHLVZwWV9FYjN4eUFNR1V5SU51dklhenBZRXJwU2F4NTNINkRESmJVVEp0bGkwT2EzcDVvRXAtWnQyMllBckNTVWlfcVlIMFk4WHRGT1owdVI5ZUc3cEhUMzZVa3FPX2dHVHdBZUY4RUxLUEszZmd2T292bEZXeDFZdlgwVi1kN3ZTYjVFWU1FdkNWdlgxOWtEaTdTR3c?oc=5","date":"2026-03-17","type":"pipeline","source":"sundayguardianlive.com","summary":"Stocks to Watch today, March 17: RIL, Union Bank,IndiGo, Tata Motors, Sun Pharma & More In Focus - sundayguardianlive.com","headline":"Stocks to Watch today, March 17: RIL, Union Bank,IndiGo, Tata Motors, Sun Pharma & More In Focus","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-22","type":"pipeline","source":"Business Standard","summary":"Stem cell therapy: How Abhay Deol found relief from chronic pain - Business Standard","headline":"Stem cell therapy: How Abhay Deol found relief from chronic pain","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxNWFNCSHNFOXotRmJyZDhzWnlLRzB0bnQ5eG1wSDk2bGJDa2wtX3g2M0RBWW5ZT0E5aU0zdGZBclRoTlJJNFQ1UHpfSVpkX3VXZklyN2lxV0sycHFrRFpINnNld2ZFMVpFZDlMejlKdHFsLWppZjYtQUVoMi1vUE1ncWZKWHQycjFxWFVaN1dmRFJmZVhLdEN0dnR5blFPRDdfUFg4ekptTFVWSTRfdWx2TjgtQTRqWm8?oc=5","date":"2026-01-05","type":"trial","source":"Fierce Biotech","summary":"Zenas' stock sinks in wake of autoimmune phase 3 data despite primary endpoint hit - Fierce Biotech","headline":"Zenas' stock sinks in wake of autoimmune phase 3 data despite primary endpoint hit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugJBVV95cUxNRHZoa3dzVUdMdW9KVFRqMkgwUmllWFBIVFdCSEYzbDk4NmVNY0xUWDVUYUpseU0zcERwSFhZNmxaQWxWdjY5NWxueGs1aFR0a3VmOEh3NmVYejQ4QlBYVlgxNUN6Tng3b3VBaEF2Q0lCWDNnaUxjd3hMX2tBVFZHNU9pRl9kbHNCSTI1VXEwRF9xOF8tbTN1R1RyNnFBWnd4Vm9xUWs5NV83dVFiN21BWk1WMS1HMHJISmd5RWRVTThUUE9aVTRuUjJwb0xueWlrS2V2bXR0UW1xUGxYRm5HQ0pwYUtYTF9mSnhHaW1EZzJLTENFTDdxR2F1QUxKT0tvLWpSVTdTT3J1RmVITlQ3RnBLNFVBaDF5akRweXZlZHVaU3MzQjI1RldoWmN1S1YxS0JIMV8wbTBLdw?oc=5","date":"2026-01-05","type":"trial","source":"GlobeNewswire","summary":"Zenas BioPharma Announces Positive Results from Phase 3 - GlobeNewswire","headline":"Zenas BioPharma Announces Positive Results from Phase 3","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxPVXdwU2tURjRiazBTbUxwWnJRSWxzUEE2d2pIWUhTY2k5d1lSMkR6aFpjM25OTDEzbW5YWlB6QmNpMVlRcFR6emtDSU1rb2JMaElCbFJNWG5aWXQ4cjRKZk80SUk5TDdSVjVqX2ZWWnp4RXppQlhpMEhRUmZDbWdTVkFkcVRuNWg1SzVUendZZlhqZ0UwZVlVMjJhTVNIblVJOS14Q21NODZUV1A4SGNnWDJZRTlYUnhMVFl3Vy01SGhibDZ6dnUwcm9adE5jSENqZGxCYVlqRV9Waldrc1poMA?oc=5","date":"2025-12-03","type":"deal","source":"PR Newswire","summary":"Sagent Launches Bludigo®, an Indigo Carmine Injection, Through New Partnership with Provepharm - PR Newswire","headline":"Sagent Launches Bludigo®, an Indigo Carmine Injection, Through New Partnership with Provepharm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wJBVV95cUxOS3lPYV9SZFBTZHdrWldhcktlUUg0b180VlhrZmxCWXZibGFNQlRXYmpBUi1CSldjVzJ6R3M1bmJYMFBKQzd3WjBlNDNOdFYtSjRxTDZHOGNET1RhT1c3a0FrNDZmOVpBQkhrQmJHdkRWLVNHOUUta0hUc29vN0tYLUNVT3l5b05qSHRHVFg5bzRUdW91ZDhrS0lQVjVBUWNVam5JeDZnSVBoXzRLM2syM3JMQTVEeWhJWXFlZTFGY0lZakNPZHBSdVY4TlhmMW9jS1lwd3NBVElMY0Q5TDNsb2hPOWdxY0xKaFZfUkRLbFZlQWpmTmVvRmZMbVhmNXczVVdNTk9rcl95Qm9HTnNvQ3B0eEwyZ2NiRUFNdVZldkFSX2REak03bUNhSkZJVHVTUERsdDZYSldUT2d6VDFOa05vMmZFbzRFcjFtUF9YZXoxRlZaSXBjaUpfdk5aa2NhUzRv?oc=5","date":"2025-11-03","type":"trial","source":"PR Newswire","summary":"Servier Announces Positive Findings from Longer-Term Analysis of the Phase 3 INDIGO Trial Showing Continued Durable Treatment Effect of VORANIGO® (vorasidenib) Published in The Lancet Oncology - PR Ne","headline":"Servier Announces Positive Findings from Longer-Term Analysis of the Phase 3 INDIGO Trial Showing Continued Durable Trea","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxNVFhvbXZzbzZKalE5dTNiN2I2ZThuRGFZTGZGamU4SUkwX0ZqbWNTNVdXbUgwT1RoTWt5NmxVSnV6RE5ZcUV6aFhjODV4ZndzX1VNSlFBbkJHSzFwYnItb2JtNDRDZzFuUVNsT1E0TkNheWl4c0pKalVMTlZPTVlVYVFFZEZqcjg3YTAxVVJvVVpFSHJ0Y2gxTzVoX1VPZXJXRTNCVTFENUE1UFZXWlVPQlp3ZE9JM2xsTU9wc28tOGpzOFhmZTlrOA?oc=5","date":"2025-10-27","type":"pipeline","source":"Massachusetts Biotechnology Council","summary":"Biotech's Comeback Seems Real This Time: Why Massachusetts Is Poised to Lead the Recovery - Massachusetts Biotechnology Council","headline":"Biotech's Comeback Seems Real This Time: Why Massachusetts Is Poised to Lead the Recovery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFAyN2tYY1BoOGowdTVySzdqbUw5MXRfNEQ2UTNnZXlmejhxekFhUFJGNXFTclEwLUg3TmJIQnprN0RqRVR5cnBnelcybDRtU21OSGVXQmE4VnJWbkF0VWtR?oc=5","date":"2024-07-19","type":"pipeline","source":"nature.com","summary":"Treatment of IDH-mutant glioma in the INDIGO era - nature.com","headline":"Treatment of IDH-mutant glioma in the INDIGO era","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNZmtjMlJsNXd0X1doYklQa3RLWnVhb0NMelFZSE5vcmhBdGREX3pMeFVYVmF5ZE9Ha3Vwb3pRdHhRdm83TXlZaURaREFuMG4zeE1QZk1kVnlqNjJIOXVYRGhmbWdQOFh1M3FjdkcxNkl3RHloUEpQOFRCUGxHc0JWVElYMWtSVm5HUTRtTDlwZThpSzZUZ2RneVlIa0FWYlVXNk1maThuYS1vamVyZ2RrNzNtcUQxdjY2bS1FMzZCT1Y?oc=5","date":"2023-06-25","type":"trial","source":"ascopost.com","summary":"INDIGO Trial: IDH Inhibitor Improves Progression-Free Survival in Grade 2 IDH1/2-Mutated Gliomas - ascopost.com","headline":"INDIGO Trial: IDH Inhibitor Improves Progression-Free Survival in Grade 2 IDH1/2-Mutated Gliomas","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQQ3NkM09fcWZ4djd2bDlyam45cnVqM1JITXhCdzBRQVktaXFSV3hSTG5LS0R3eTRfak03RWRJcTJjbmhNaG5TVVg3SFlHa0JvdHRKeGZjckNGZk5rb2lQeEFZcDBfMXMySHFLR0RBQTZTOVpfWlQzTGJKbVRmRUtZTmVQSllxUTg?oc=5","date":"2023-06-05","type":"pipeline","source":"pharmaphorum","summary":"ASCO: Vorasidenib shows its glioma potential in INDIGO - pharmaphorum","headline":"ASCO: Vorasidenib shows its glioma potential in INDIGO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQdlZkRE01dks2ajZoRGdveEdRLXFOTldQc0xHUFZtUFVwMTNhUm5ObTBTcVk3Q0ZpeXgwU0drSnhkd2pJRFBMaENTUlUxVmJMdm1Yd0xRaUFXU3hGdUhZcC1iWU04OVFmdWg1ZHFDX09oTEkwd2NweTN0ZDNWU0tQVzNVb1YwNzJfRkQweTBQYnNBc3JpLXo0X0NnWUExSjMxM0hKbTVLOF96SmJfblE?oc=5","date":"2023-06-04","type":"pipeline","source":"ASCO Daily News","summary":"INDIGO: Vorasidenib Offers Patients With IDH-Mutant Low-Grade Glioma a Means to Delay Chemotherapy and Radiotherapy - ASCO Daily News","headline":"INDIGO: Vorasidenib Offers Patients With IDH-Mutant Low-Grade Glioma a Means to Delay Chemotherapy and Radiotherapy","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}